Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Cancer
|
October 22, 1998
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy
S E Pinder, S Murray, I O Ellis, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Prognostic importance of thymidylate synthase expression in early breast cancer
B C Pestalozzi, H F Peterson, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
M Colleoni, S Li, R D Gelber, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Cancer
|
October 22, 1998
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy
S E Pinder, S Murray, I O Ellis, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Prognostic importance of thymidylate synthase expression in early breast cancer
B C Pestalozzi, H F Peterson, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
M Colleoni, S Li, R D Gelber, et al.
Page
of 16